32
Word Count: 2,995 words, Reading Time: 14 minutes. Not financial advice, do your own due diligence, for entertainment purposes only.
Subscribers: Substack is telling me this post is too long for email so please load in browser if the bottom cuts off before my signature.
Today I want to talk about Delcath DCTH 0.00%↑ and why I think it’s a lower risk biotech stock now which should double in the next 12 to 15 months if they execute as I expect them to do.
I first learned about Delcath through someone pointing me to the research of Encode…